Rituxan (rituximab) - Roche
Intravascular Large B-Cell Lymphoma Presenting as Recurrent Cryptogenic Strokes: A Diagnostic Challenge. (PubMed, Case Rep Hematol) - Sep 21, 2026 - "The patient was initiated on R-CHOP and had improvement in his neurological status after the initiation of chemotherapy, and his ClonoSeq MRD testing is negative. This case is of interest given the lack of imaging findings for this patient prior to diagnosis as all of his CT scans were negative, making it a challenge to diagnose him as well as monitor his response to treatment. Additionally, his case highlights the importance of ClonoSeq MRD testing, which allows for the detection of even minimal amounts of disease in tracking response to treatment." 
Journal • B Cell Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
http://www.ncbi.nlm.nih.gov/pubmed/42763545
 
Habtemariam Dessie; Jakita Baldwin; Kimberly Stogner; Rakhee Vaidya; Roy Strowd; Sarada Krishnamurthy; Veena Krishnan
 
Sep 21, 2026
 
Prev Next